Skip to main content

Opaleye Management Inc.'s Form 4 filing

TELA Bio, Inc. (TELA) · filed Jun 10, 2022

Accession no.
0001493152-22-016481
Filed
Jun 10, 2022
Trade date
Jun 10, 2022
Filing delay
Same day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions. Open-market purchases total $154.0K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Opaleye Management Inc.CIK 000159585510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 10, 2022Common Stock, par value $0.001 per sharePPurchaseAcquired+25,000$5.60F3+$140,0001,490,000Indirect
Jun 10, 2022Common Stock, par value $0.001 per sharePPurchaseAcquired+2,500$5.60F3+$14,00095,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The common stock was purchased by the reporting person in open market transactions on the transaction date, with an average purchase price of $5.6024, and a range of $5.27-$5.80. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)